Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Cigarette smokers have a significantly lower likelihood of being diagnosed with Sjögren's disease, with histologic data showing less tissue damage and lower disease activity in smokers who have it.

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

Amylin, a pancreatic peptide hormone, is involved in the regulation of blood glucose as well as appetite; therefore, long-acting amylin analogs have gained increasing interest as monotherapy, and in ...

Chinese herb-derived compound tetrandrine shows signs of efficacy in methotrexate-treated patients with moderate to severe rheumatoid arthritis, but placebo rates are high.

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial.

A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, non-tender, non-bleeding ...

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...